发明名称 |
Selective NPY (Y5) antagonists |
摘要 |
This invention is directed to bicyclic and tricyclic compounds which are selective antagonists for NPY (Y5) receptors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention provides a pharmaceutical composition made by combining a therapeutically effective amount of a compound of this invention and a pharmaceutically acceptable carrier. The invention provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention further provides the use of a compound of the invention for the preparation of a pharmaceutical composition for treating an abnormality, wherein the abnormality is alleviated by decreasing the activity of a human Y5 receptor.
|
申请公布号 |
US7273880(B2) |
申请公布日期 |
2007.09.25 |
申请号 |
US20050040328 |
申请日期 |
2005.01.20 |
申请人 |
NOVARTIS AG |
发明人 |
MARZABADI MOHAMMAD R.;WONG WAI C.;NOBLE STEWART A.;YAMAGUCHI YASUCHIKA |
分类号 |
A61K31/426;C07D277/42;C07D277/60;C07D417/12;C07D513/04 |
主分类号 |
A61K31/426 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|